Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 20/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 17/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 16/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 11/20 | 0.40 |
| ▸ | PLK4 | O00444 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.38 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.38 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.38 |
| ▸ | CSNK1G3 | Q9Y6M4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18133300 | 0.94 | ADORA2B (0.42) | ADORA2BADORA1ADORA2AADORA3PLK4 | |
| SCHEMBL15064882 | 0.91 | ADORA2B (0.50) | ADORA2BADORA1ADORA2AADORA3PLK4 | |
| SCHEMBL796991 | 0.83 | ADORA2B (0.50) | ADORA2BADORA1ADORA2AADORA3PLK4 | |
| SCHEMBL18133294 | 0.82 | ADORA2B (0.46) | ADORA2BADORA1ADORA2AADORA3PLK4 | |
| SCHEMBL15064746 | 0.81 | ADORA2B (0.48) | ADORA2BADORA1ADORA2AADORA3PLK4 | |
| SCHEMBL15064429 | 0.81 | ADORA2B (0.54) | ADORA2BADORA1ADORA2AADORA3PLK4 | |
| SCHEMBL15064477 | 0.81 | ADORA2B (0.48) | ADORA2BADORA1ADORA2AADORA3PLK4 | |
| SCHEMBL30891831 | 0.80 | ADORA2B (0.47) | ADORA2BADORA1ADORA2AADORA3PLK4 | |
| SCHEMBL797120 | 0.80 | ADORA2B (0.47) | ADORA2BADORA1ADORA2AADORA3PLK4 | |
| SCHEMBL30891869 | 0.79 | ADORA2B (0.51) | ADORA2BADORA1ADORA2AADORA3PLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012035548-A1 | PURINE COMPOUNDS AS PRODRUGS OF A2B ADENOSINE RECEPTOR ANTAGONISTS, THEIR PROCESS AND MEDICINAL APPLICATIONS | ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) | 2012-03-22 | — | — | WO | disclosed |